Search Results

There are 75293 results for: content related to: Pathophysiology of motor fluctuations in Parkinson's disease

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  3. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  4. Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 19, Issue 12, December 2012, Pages: 1502–1508, O. Gershanik and P. Jenner

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1468-1331.2011.03593.x

  5. Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 1–9, John G. Nutt

    Version of Record online : 6 SEP 2006, DOI: 10.1002/mds.21060

  6. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  8. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  9. Poster session 2, Abstracts 345–694

    Movement Disorders

    Volume 19, Issue S9, 2004, Pages: S129–S244,

    Version of Record online : 10 MAY 2004, DOI: 10.1002/mds.20176

  10. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

    Movement Disorders

    Volume 13, Issue 2, March 1998, Pages: 336–338, Nadir Syed, John Murphy, Thomas Zimmerman Jr., Margery H. Mark and Jacob I. Sage

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130222

  11. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  12. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  13. Poster Session 2

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S425–S516,

    Version of Record online : 20 SEP 2006, DOI: 10.1002/mds.21247

  14. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort

    European Journal of Neurology

    Volume 15, Issue 7, July 2008, Pages: 643–648, P. Damier, F. Viallet, M. Ziegler, I. Bourdeix and K. Rerat

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1468-1331.2008.02165.x

  15. Pharmacokinetics and pharmacodynamics of levodopa

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S580–S584, John G. Nutt

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22037

  16. Interventions to Achieve Tonic Exposure to Levodopa: Delaying or Preventing the Onset of Motor Complications

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 11P2, November 1999, Pages: 169S–179S, Mark S. Luer

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.17.169S.30886

  17. Maximizing the Benefit: Risk Ratio of Levodopa Therapy in Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 11P2, November 1999, Pages: 162S–168S, Mildred D. Gottwald

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.17.162S.30884

  18. REVIEW

    European Journal of Neuroscience

    Volume 6, Issue 6, June 1994, Pages: 889–897, J. A. Obeso, F. Grandas, M. T. Herrero and R. Horowski

    Version of Record online : 7 APR 2006, DOI: 10.1111/j.1460-9568.1994.tb00584.x

  19. Pharmacotherapy and Treatment of Parkinson's Disease

    Standard Article

    Handbook of Contemporary Neuropharmacology

    Wing Lok Au and Donald B. Calne

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn062

  20. Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations

    Movement Disorders

    Volume 20, Issue S11, May 2005, Pages: S30–S37, Katherine L. Widnell and Cynthia Comella

    Version of Record online : 8 APR 2005, DOI: 10.1002/mds.20461